/
/
/

Gujarat Kidney And Super Speciality Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
₹34 Cr₹31 Cr₹23 Cr₹13 Cr₹15 Cr₹10 Cr₹12 Cr₹9 Cr
₹69 L₹71 L₹6 L₹9 L₹80,000₹5 L₹5 L₹5 L
₹35 Cr₹31 Cr₹23 Cr₹13 Cr₹15 Cr₹10 Cr₹12 Cr₹9 Cr
₹27 Cr₹26 Cr₹18 Cr₹9 Cr₹8 Cr₹8 Cr₹8 Cr₹5 Cr
₹9 Cr₹7 Cr₹7 Cr₹5 Cr₹9 Cr₹3 Cr₹5 Cr₹5 Cr
₹66 L₹82 L₹60 L₹28 L₹18 L₹16 L₹17 L₹16 L
₹7 Cr₹5 Cr₹5 Cr₹4 Cr₹7 Cr₹2 Cr₹4 Cr₹4 Cr
₹5 Cr₹5 Cr₹4 Cr₹3 Cr₹5 Cr₹1 Cr₹3 Cr₹3 Cr

Share Price Live Stats

Open (₹)172.88
Volume (₹)1.06 L
High (₹)174.69
Upper Circuit205.81
Low (₹)172.46
Lower Circuit137.21
Prev Close171.51
52W High (₹)175.26
Price172.68
52W Low (₹)98.36

Share Market Cap & Key Ratios Overview

M.Cap (₹)1354.13 Cr
Div. Yield (%)0.00
PE Ratio85.52
Debt to Equity0.15
Price to Book0.00
Book Value4.56
EPS (TTM)2.01
Face Value2.00
ROE (%)68.65

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
APOLLOHOSPNSE
MAXHEALTHNSE
MANIPALHOSNSE
FORTISNSE
ASTERDMNSE
NHNSE
MEDANTANSE
LALPATHLABNSE
KIMSNSE
AGARWALEYENSE
GKSLNSE
LTP
1W Low
1W High
Market cap (₹)
8687.5-151 (-1.71%)
8640
8902
1,26,300Cr
998.5-15.6 (-1.54%)
985.50
1042.10
96,763Cr
732.25-39.4 (-5.11%)
702
784
95,496Cr
911.8-14.95 (-1.61%)
893
929
68,901Cr
786.55+38.15 (5.10%)
745.05
792.05
68,592Cr
1878-54.1 (-2.80%)
1875.90
1949.60
38,439Cr
1473.3+1.1 (0.07%)
1410
1500.10
38,149Cr
1875.9-55.2 (-2.86%)
1855.70
1963
32,259Cr
770.8-0.2 (-0.03%)
748.30
778.55
32,231Cr
510.85+3.05 (0.60%)
502
524.50
16,249Cr
172.68+12.04 (7.50%)
156.64
175.26
1,354Cr

Key Highlights of Gujarat Kidney And Super Speciality Ltd’s P&L

In 2025-03-31, Gujarat Kidney And Super Speciality Ltd reported total revenue of ₹40.4Cr, compared with ₹5.48Cr in 2024-03-31, reflecting Gujarat Kidney And Super Speciality Ltd turnover.

Depreciation was ₹3.29Cr and finance costs were ₹64.63Lakh in 2025-03-31

Profit Before Tax (PBT) has been ₹12.77Cr in 2025-03-31 as compared to ₹2.27Cr in 2024-03-31.

Net Profit (PAT) was ₹9.41Cr in 2025-03-31 compared with ₹1.71Cr in 2024-03-31.

Earnings per share (EPS) were ₹1.66 in 2025-03-31, compared with ₹85.70 in 2024-03-31.